UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...
United Commercial Bank PLC (UCB) held its 506th Meeting of the Board of Directors on Tuesday at the bank's corporate office. ...
How the comedy roots of “Saturday Night Live” cast members over 50 seasons have helped make the show unpredictable and ...
Morgan Stanley raised the firm’s price target on UCB (UCBJF) to EUR 200 from EUR 105 and keeps an Equal Weight rating on the shares.Maximize ...
Morgan Stanley analyst Sarita Kapila assumed coverage of UCB (UCBJF) with an Equal Weight rating and EUR 200 price target The firm says the ...
The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...
UCB SA (OTCMKTS:UCBJF – Get Free Report) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 396,800 shares, a growth of 25.7% from the ...
After two years of treatment with bimekizumab, 53.1% of patients experienced mild disease compared to none at baseline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results